← Study Library
Meta-analysis · 2011 · n=326
Preclinicalcounts toward this tierMeta-analysis of the related nutritional supplements dimethyl sulfoxide and methylsulfonylmethane in the treatment of osteoarthritis of the knee
Brien S, Prescott P, Lewith G · Evidence-Based Complementary and Alternative Medicine
Preclinicalcounts toward this tier
The pooled result was NOT significant: a 6.34 mm reduction on the visual analogue pain scale (SE 3.49, 95% CI -0.49 to 13.17), with an overall effect size of 1.82 that was neither statistically nor clinically significant. The authors' conclusion is blunt — 'Current evidence suggests DMSO and MSM are not clinically effective in the reduction of pain in the treatment of OA.'
- Population
- Three randomized controlled trials in knee osteoarthritis — two of DMSO, one of MSM
- Intervention
- Dimethyl sulfoxide or methylsulfonylmethane
- Comparator
- Placebo or control
- Limitations
- Only three trials met inclusion and only ONE of them tested MSM, so this is weak evidence against MSM specifically rather than a decisive refutation. Significant heterogeneity. The authors also note inadequate dosing periods, and say no definitive conclusions can be drawn. Independent (University of Southampton).
Cited by
2 entries reference this study
- MSM (methylsulfonylmethane)PROM.
Supplements → Anti-inflammatories
- Sulfur & sulfatePRECL.
Foods & Nutrition → Collagen, ingredient by ingredient